Jubilant Generics Limited

FDA inspection history across 3 sites, 2018 to 2024

4
Form 483s
2
Close-outs

Every document, by year

  • Close-out
  • Form 483

2018: one Form 483; 2019: one close-out letter; 2021: one Form 483; 2022: one Form 483; 2024: one close-out letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018–24Four Form 483s and two close-out letters, at Roorkee, India; Hardiwar, India and Sikanderpur Bhainswal, India.
  2. 2021The longest 483 on file: 7 observations over 16 pages at Hardiwar, India.

Cited most

Across all Jubilant Generics Limited observations on file

The complete Jubilant Generics Limited file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Also: two documents not tied to a site.

Documents

6 on file, newest first
DateDocumentPrice
2024-04-23Close-out Close-out letter$99
2024-02-02483 Form 483$99
2022-08-01483 Form 483$99
2021-03-12483 Form 483$99
2019-03-06Close-out Close-out letter$99
2018-08-08483 Form 483$99

FEI number 3006895982 · most recent document Apr 23, 2024

About Jubilant Generics Limited

How many FDA Form 483s has Jubilant Generics Limited received?

FDA Intel has 4 Form 483s on file for Jubilant Generics Limited; the most recent is dated Feb 2, 2024.

When was Jubilant Generics Limited last inspected by FDA?

The most recent FDA inspection document on file for Jubilant Generics Limited is a Form 483 dated Feb 2, 2024, for the site in Roorkee, India.

What did FDA cite at Jubilant Generics Limited?

The regulations cited most in the observations on file for Jubilant Generics Limited are 21 CFR 211.192 (Production record review), 6 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 3 times; 21 CFR 211.22 (Responsibilities of quality control unit), 3 times.